Immunicum welcomes investors, media and the public to virtually attend a Corporate Update Event on September 30, 2020 at 18.00 CEST.

During the event, Immunicum’s newly appointed CEO, Sven Rohmann, will be presenting some of the key strategic pillars coming out of his recent appointment, together with other members from the management team. The team will also provide an overview of recent achievements, next steps and the Company’s long-term mission.

Following the completion of the presentation, audience members will have the opportunity to ask questions in person or through the webcast video chat. Immunicum recommends those interested to submit their questions ahead of the event to the following email address: ir@immunicum.com.

Everyone will be able to participate virtually after a quick registration to Redeye’s platform.

Sven Rohmann, MD, PhD, MBA
Chief Executive Officer

Alex Karlsson-Parra, MD, PhD, Adjunct Professor in Clinical Immunology, Uppsala University, Sweden
Chief Scientific Officer & Founder

Sijme Zeilemaker, MSc
Chief Operating Officer